Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Series C Convertible Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Series A Preferred Stock [Member] Additional Paid in Capital Series A Preferred Stock [Member] Series B Preferred Stock [Member] Additional Paid in Capital Series B Preferred Stock [Member] Series C Preferred Stock [Member] Additional Paid in Capital Series C Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Subscription Receivable [Member] Retained Earnings [Member] Product and Service [Axis] Brachytherapy Product Line [Member] Sale of Stock [Axis] Regulation A+ Offerings [Member] Private Placement [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Radionuclide Therapy Product Line [Member] Statistical Measurement [Axis] Maximum [Member] Intangible Asset, Finite-Lived, Class [Axis] Intellectual Property [Member] Services - Treatments [Member] IsoPet [Member] Certification [Member] Freight [Member] Polymer [Member] Discount - Services [Member] Discount - IsoPet [Member] Discount - Certifications [Member] Antidilutive Securities [Axis] Restricted Stock Units (RSUs) [Member] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Title and Position [Axis] Chief Executive Officer [Member] Long-Lived Asset, Class [Axis] Equipment [Member] Office Equipment [Member] Minimum [Member] Award Type [Axis] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Customer [Axis] Three Customers [Member] Six Customers [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Employment Agreement [Member] Dr. Michael K. Korenko [Member] Consultants [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] ASSETS Current Assets: Cash Accounts receivable Inventory Prepaid expenses Total Current Assets Fixed assets, net Other Assets: Right of use assets Other assets Total Other Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY LIABILITIES Current Liabilities: Accounts payable and accrued expenses Current portion of lease liability Total Current Liabilities Non-current Liabilities: Lease liability, net of current portion Total Non-current Liabilities Total Liabilities Commitments and contingencies STOCKHOLDERS’ EQUITY Preferred stock, value Additional paid in capital Common stock, par value, $0.001, 950,000,000 shares authorized, 482,840,608 and 455,494,238 issued and outstanding, respectively Additional paid in capital - common stock Accumulated deficit Total Stockholders’ Equity TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues, net Cost of Goods Sold Gross loss OPERATING EXPENSES Professional fees, including stock-based compensation Payroll expenses Research and development General and administrative expenses Total Operating Expenses OPERATING LOSS NON-OPERATING INCOME Interest income Loss on issuance of shares and warrant exchange Total Non-Operating Income NET LOSS BEFORE PROVISION FOR INCOME TAXES Provision for income taxes NET LOSS Net loss per share - basic Net loss per share - diluted Weighted average common shares outstanding - basic Weighted average common shares outstanding - diluted Balance Balance, shares Cash Cash, shares Services Services, shares Exercise/Exchange of warrants (cash and cashless) Warrants purchased for cash RSUs granted to consultants that have vested Net loss for the period Exercise of warrants (cash and cashless), shares Vested RSUs Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOW FROM OPERTING ACTIVIITES Net loss Adjustments to reconcile net loss to net cash used in operating activities Depreciation Common stock, stock options and warrants for services RSUs issued for services Loss on issuance of shares and warrant exchange Changes in assets and liabilities Accounts receivable Inventory Prepaid expenses and other assets Accounts payable and accrued expenses Operating lease expense Total adjustments Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES Purchases of fixed assets Net cash (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITES Payments of lease liability Exercise of warrants Proceeds from common stock and warrants Net cash provided by financing activities NET INCREASE IN CASH CASH - BEGINNING OF PERIOD CASH - END OF PERIOD CASH PAID DURING THE PERIOD FOR: Interest expense Income taxes Accounting Policies [Abstract] BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Property, Plant, and Equipment [Abstract] FIXED ASSETS Equity [Abstract] STOCKHOLDERS’ EQUITY COMMON STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK UNITS Leases LEASES Risks and Uncertainties [Abstract] CONCENTRATIONS Commitments and Contingencies Disclosure [Abstract] COMMITMENT Subsequent Events [Abstract] SUBSEQUENT EVENTS Going Concern Financing and Strategy Consolidation Use of Estimates Financial Statement Reclassification Cash Equivalents Fair Value of Financial Instruments Fixed Assets Patents and Intellectual Property Revenue Recognition Inventory Loss Per Share Research and Development Costs Advertising and Marketing Costs Contingencies Income Taxes Stock-Based Compensation Segment Reporting Recent Accounting Pronouncements SCHEDULE OF DISAGGREGATION OF REVENUE SCHEDULE OF DILUTIVE EARNINGS PER SHARE SCHEDULE OF FIXED ASSETS SCHEDULE OF CHANGES IN STOCK OPTION SCHEDULE OF CHANGES IN STOCK WARRANTS SCHEDULE OF ASSUMPTIONS USED IN FAIR VALUE MEASUREMENT SCHEDULE OF CHANGES IN RESTRICTED STOCK UNITS SCHEDULE OF OPERATING LEASE MATURITY SCHEDULE OF LESSEE RIGHT OF USE OF ASSET AMORTIZATION SCHEDULE OF LEASE COST Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Total  Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total potential dilutive securities Amount annually to maintain operating activities Value of shares issuable Sale of stock value Number of common stock shares issued, value Number of common stock shares issued, shares Number of warrants issued Value of warrants issued Cash on hand Offering term Property, Plant, and Equipment, Useful Life Finite lived intangible asset useful life Finite lived intangible asset amortization period Research and development costs Related Party Transaction [Table] Related Party Transaction [Line Items] Advance from officer Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] Office equipment – 5 year-life Production equipment useful life Accumulated depreciation Fixed assets, net  Depreciation expenses Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of Options Outstanding, Beginning Balance Weighted Average Exercise Price Per Share Outstanding Beginning Balance Weighted Average Remaining Contractual Life (in years) Outstanding Aggregate Intrinsic Value Outstanding Beginning Weighted Average Exercise Price Per Share Outstanding Beginning Number of Options, Granted Exercise Price Per Share, Granted Weighted Average Exercise Price Per Share Options Granted Number of Options, Exercised Exercise Price Per Share, Exercised Weighted Average Exercise Price Per Share Options Exercised Number of Options, Expired/cancelled Exercise Price Per Share, Expired/cancelled Weighted Average Exercise Price Per Share Options Expired/cancelled Number of Options Outstanding Ending Balance Weighted Average Exercise Price Per Share Outstanding Ending Aggregate Intrinsic Value Outstanding Ending Weighted Average Exercise Price Per Share Outstanding Ending Number of Options Exercisable Weighted Average Exercise Price Per Share Exercisable Weighted Average Remaining Contractual Life (in years) Exercisable Aggregate Intrinsic Value Exercisable Weighted Average Exercise Price Per Share Exercisable Stock, Class of Stock [Table] Class of Stock [Line Items] Preferred stock, liquidation preference per share Conversion price per share Gross proceeds from preferred stock Preferred stock redemption, description Preferred stock voting rights, description Shares converted Shares issued Number of share issued for services Issued for services, value Number of shares issued Proceeds from issuance of common stock Recognized loss exchange Proceeds from warrants exercised Sale of stock, number of shares issued Number of Shares, Warrants Outstanding Beginning Exercise Price Per Share Warrants Outstanding Beginning Weighted Average Remaining Contractual Life Warrants Outstanding Aggregate Intrinsic Value Warrants, Beginning Weighted Average Exercise Price Per Share Warrants, Beginning Number of Shares, Warrants granted Exercise Price Per Share Warrants, Granted Weighted Average Exercise Price Per Share Warrants, Granted Number of Warrants, Redeemed Exercise Price Per Share Warrants, Redeemed Number of Warrants, Exercised Exercise Price Per Share Warrants, Exercised Number of Warrants, Exchanged Exercise Price Per Share Warrants, Exchanged Number of Warrants, Expired/cancelled Exercise Price Per Share Warrants, Expired/cancelled Number of Warrants Outstanding, Ending Exercise Price Per Share Warrants Outstanding, Ending Aggregate Intrinsic Value Warrants, Ending Weighted Average Exercise Price Per Share Warrants, Ending Number of Warrants, Exercisable Exercise Price Per Share Warrants, Exercisable Weighted Average Remaining Contractual Life Warrants, Exercisable Aggregate Intrinsic Value Warrants, Exercisable Weighted Average Exercise Price Per Share Warrants, Exercisable Expected term Expected volatility Expected dividend yield Risk-free interest rate Number of Shares, RSU's Beginning balance Weighted Average Grant Date Fair Value, RSU's Outstanding Beginning Number of Shares, RSU's granted Weighted Average Grant Date Fair Value, RSU's granted Number of Shares, RSU's vested Weighted Average Grant Date Fair Value, RSU's vested Number of Shares, RSU's forfeited Weighted Average Grant Date Fair Value, RSU's forfeited Number of Shares, RSU's Ending balance Weighted Average Grant Date Fair Value, RSU's Outstanding Ending Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Stock based compensation Number of warrants, granted Exercise price per share warrants granted Warrants expiration date Reprise of warrants Exercise price of warrants Restricted stock expense vesting Restricted stock expenses yet to be recognized Restricted stock units vested Restricted stock units granted Schedule Of Operating Lease Maturity 2027 2028 2029 2030 Imputed interest Total lease liability Current portion Non-current portion Schedule Of Lessee Right Of Use Of Asset Amortization Amortization of the right of use asset for the period ended March 31, 2027 2028 2029 2030 Total Operating lease expense Lessee, operating lease, discount rate Lessee, operating lease, term of contract Unamortized lease right of use asset Operating lease, liability Concentration Risk [Table] Concentration Risk [Line Items] Concentration risk, percentage Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Agreement term description Base compensation Discretionary bonus Granted restricted stock units Vesting period Subsequent Event [Table] Subsequent Event [Line Items] Number of shares issued Series A Convertible Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Series C Convertible Preferred Stock [Member] Regulation A+ Offerings [Member] Gain loss recognized loss exchange warrants. Proceeds from common stock and warrants. Share based compensation arrangement by share based payment award options exercisable weighted average exercisable price. Stock Option Plans Exercise Price. Weighted Average Exercise Price Per Share Options granted. Weighted Average Exercise Price Per Share Options Exercised. Weighted average exercise price per share option expired. Exercisable Weighted Average Exercise Price Per Shares. Additional Paid in Capital Series A Preferred Stock [Member] Additional Paid in Capital Series B Preferred Stock [Member] Additional Paid in Capital Series C Preferred Stock [Member] Subscription Receivable [Member] Stock issued during period value exercise of warrants. Stock issued during period shares exercise of warrants. Restricted stock units issued for services. Share based compensation arrangement by share based payment award non option equity instruments exchanged. The number of shares into which fully or partially vestednon-option equity outstanding as of the balance sheet date can be currently converted under the non-option equity plan. Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares, others. Share based compensation arrangement by share based payment award non option equity instruments exchanges in period weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments expired in period weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercisable price. Going Concern [Policy Text Block] Brachytherapy Product Line [Member] Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. Financing And Strategy [Policy Text Block] Weighted average remaining contractual term for vested portions of non-option equity outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Sharebased compensation arrangement by sharebased payment award non options outstanding intrinsic value. Sharebased compensation arrangement by sharebased payment award non options exercisable intrinsic value. Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price per share. Share based compensation arrangement by share based payment award non option equity instruments granted weighted average exercise price per share. Exercise Price Warrant Exercisable. Radionuclide Therapy Product Line [Member] Offering term. Fixed Assets [Policy Text Block] Warrants reprisew. Lessee operating lease liability undiscounted amount. Lessee Right of use Asset Future Amortization Expense [Table Text Block] Right of use asset amortization expense year two. Right of use asset amortization expense year three. Right of use asset amortization expense year four. Two Customers [Member] Three Customers [Member] Agreement term description. Employment Agreement [Member] Dr. Michael K. Korenko [Member] Discretionary bonus. Consultants [Member] Right of use asset amortization expense next 12 months. Services - Treatments [Member] IsoPet [Member] Certification [Member] Freight [Member] Polymer [Member] Discount - Services [Member] Discount - IsoPet [Member] Discount - Certifications [Member] Assets, Current Other Assets Assets Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Stock Issued During Period, Value, New Issues Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity Payments to Acquire Property, Plant, and Equipment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Repayments of Debt and Lease Obligation Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Equity [Text Block] Inventory, Policy [Policy Text Block] Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisablePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePricePerShares Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePricePerShare Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExchanged Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisablePrice SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1 WeightedAverageExercisePricePerShareExercisePriceWarrantExercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period LesseeOperatingLeaseLiabilityUndiscountedAmount RightofuseAssetAmortizationExpenseYearTwo RightofuseAssetAmortizationExpenseYearThree RightofuseAssetAmortizationExpenseYearFour Operating Lease, Expense